Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized 4-week trial of GRT6005 for painful diabetic polyneuropathy
2010-022557-42Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cebranopadol in diabetic polyneuropathy (DPN) (4 arms), sponsored by Grünenthal GmbH. Primary endpoint: Change from baseline in pain intensity score during the last treatment week. Started Dec 2010; status: completed.
02
Drugs
cebranopadol
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2010-022557-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022557-42.